Development and validation of a HPLC method for 4,7-phenanthroline-5,6- dione 1 and identification of its major impurity by HPLC-MS-APCI

Journal of Chromatographic Science

Volumn 43, Issue 4, 2005, Pages 207-212

  Shabir, Ghulam A ^a   Forrow, Nigel J ^a  

^a ABBOTT LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 19944403241     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/43.4.207     Document Type: Article

References (21)

1. F. Kradolfer, W. Sachmann, and C.T. Bassil. Comparative microbiological studies of amebicides with special reference to the derivatives of phenanthroline quinone. Ann. Biochem. Exptl. Med. 20:519-27 (1960).
2. M. Xilinas and P.M. Cerolymatos. Use of Phanquinone for the Treatment of Alzheimer's Disease. PCT Int. Appl. WO 9909981, January 6, 1999.
3. M. Xilinas and P.M. Cerolymatos. Use of Phanquinone for the Treatment or Prevention of Memory Impairment. PCT Int. Appl. WO 0040244, March 20, 2000.
4. M. Xilinas. Use of Phanquinone and Clioquinol for the Treatment and Prevention of Ocular Macular Diseases. Fr. Pat. Appl. 2819187, July 12, 2002.
5. M. Xilinas. Use of Chelators in the Treatment of Macular Degenerative Disease. PCT Int. Appl. WO 0255081, July 18, 2002.
6. M. Xilinas and C. Hannoun. Use of Sequestrants for Treating Prion Diseases. PCT Int. Appl. WO 0251415, July 4, 2002.
7. M. Xilinas. Use of Phanquinone for the Treatment of Pathological Conditions Caused by the Action of Matrix Metalloproteinases. PCT Int. Appl. WO 0182912, November 8, 2001.
8. P. Bonhote and M.S. Wrighton. Facile Synthesis of tetrapyrido[2,3a: 3′,2′-c:2″,3″-h:3‴,2‴-j]phenazine. Synlett. 8:897-98 (1997).
9. A. Gourdon. One-step synthesis of tetrapyrido[2,3-a:3′,2′-c: 2″,3″-h:3‴,2‴-j]phenazine and dibenzo[a:c](dipyrido[2, 3-h:2′,3′-j])phenazine. Synth. Commun. 27:2893-97 (1997).
10. S. Imor, R.J. Morgan, S. Wang, O. Morgan, and A.D. Baker. An improved preparation of 4,7-phenanthrolino-5,6:5′,6′-pyrazine. Synth. Commun. 26:2197-2203 (1996).
11. D.M. D'Alessandro, L.S. Kelso, and F.R. Keene. Stereochemical influences on intervalence charge transfer in homodinuclear complexes of ruthenium. Inorg. Chem. 40:6841-44 (2001).
12. M. Conlin, H.S. Forrest, and T.C. Bruice. Replacement of methoxatin by 4,7-phenanthroline-5,6-dione and the inability of other phenanthroline quinones, as well as 7,9-didecarboxymethoxatin, to serve as cofactors for the methoxatin-requiring glucose dehydrogenase of Acinetobacter calcoaceticus. Biochem. Biophys. Res. Commun. 131:564-66 (1985).
13. S. Itoh, H. Fukushima, M. Komatsu, and Y. Ohshiro. Heterocyclic o-quinones. Mediator for electrochemical oxidation of NADH. Chem.Lett. 8:1583-86 (1992).
14. I.S. Protopopov, M. Ya. Kraft, A.S. Vlasov, and T.Z. Kukushkina. New Preparation of 4,7-Phenanthroline-5,6-Dione. Brit. Pat. 1056297, January 25, 1967.
15. M. Yamada, Y. Tanaka, Y. Yosimoto, S. Kuroda, and I. Shimao. Synthesis and properties of diamino-substituted dipyrido[3,2-a: 2′,3′-c] phenazine. Bull. Chem. Soc. Jpn. 65:1006-11 (1992).
16. 2+. 115:J. Am. Chem. Soc. 3448-54 (1993).
17. F. Calderazzo, F. Marchetti, G. Pampaloni, and V. Passarelli. Co-ordination properties of 1,10-phenanthroline-5,6-dione towards group 4 and 5 metals in low and high oxidation states. J. Chem. Soc., Dalton Trans. 24:4389-96 (1999).
18. J. Mlochowski. Investigations on reactivity of phenanthrolines. Part III. Bromination of phenanthrolines. Rocz. Chem. 48: 2145-55 (1974).
19. P.M. Degen, S. Brechbühler, J. Schäublin, and W. Riess. The determination of phanquone in biological material by gas-liquid chromatography. J. Chromatogr. A. 118: 363-70 (1976).
20. M.G. Gioia, R. Gatti, M. Vannini, and M. Hudaib. 4,7-Phenanthro-line-5,6- dione: A new labelling reagent for liquid Chromatographic analysis of amino acids. Chromatographia. 56:289-94 (2002).
21. G.A. Shabir and N.J. Forrow. Validation of a reversed-phase HPLC method for 1,10-phenanthroline-5,6-dione and analysis of its impurities by HPLC-MS. J. Pharm. Biomed. Anal. 33:219-30 (2003).